Trial intelligence / Profile preview

Zanubrutinib + Obinutuzumab + CHOP for First-line Mantle Cell Lymphoma

ChiCTR2500108714Phase 2Not yet recruiting

Sponsor

First Affiliated Hospital, Zhejiang University School of Medicine

Start

Sep 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1